Cite
HARVARD Citation
MacDonagh, L. et al. (2018). BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC. Cancer letters. pp. 117-126. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
MacDonagh, L. et al. (2018). BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC. Cancer letters. pp. 117-126. [Online].